Sanofi to sell Paris R&D park
Sanofi has agreed to sell a life sciences park it owns on in Paris, France to public investment group, Caisse de Depots (CDC).
Archives for December 10, 2013
SynteractHCR selected for Phase III trial of diabetic nasal spray
Evoke Pharma has selected SynteractHCR to carry out Phase III trials of its nasal spray drug EVK-001.
Puerto Rico must address rising costs to ensure pharma future, says expert
Puerto Rico’s drug manufacturing industry has no future unless utility costs and taxes are controlled, according to a regulatory expert.
Venn continues growth with $1.1m purchase of Northern Irish CRO
Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.